Endobronchial Valves for Challenging Air Leaks

Reed, Michael F.; Gilbert, Christopher R.; Taylor, Matthew D.; Toth, Jennifer

doi:10.1016/j.athoracsur.2015.04.104

Cited by 62 publications

(41 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The most commonly used modalities are: mechanical debulking using flexible or rigid bronchoscopy, laser photoresection, APC, cryotherapy, electrocautery, brachytherapy and photodynamic therapy (PDT) [Ernst et al 2004]. In some benign conditions, therapeutic bronchoscopy can be offered as an alternative to other therapies, such as in bronchoscopic lung volume reduction using endobronchial valves or coils, bronchial thermoplasty for refractory asthma [Davey et al 2015;Denner et al 2015;Gompelmann et al 2015] and endobronchial valves for persistent air leaks [Reed et al 2015]. However the theoretical risk of bleeding in such cases is low compared with procedures involving debulking of tumors, or manipulating stents in vascular areas of airways involved with tumors.…”

Section: Discussionmentioning

confidence: 99%

Aspirin use and the risk of bleeding complications after therapeutic bronchoscopy

Harris

Kebbe

Modi

et al. 2016

Ther Adv Respir Dis

View full text Add to dashboard Cite

Background: Aspirin use has been shown to be safe for patients undergoing certain diagnostic bronchoscopy procedures such as transbronchial biopsies and endobronchial ultrasound (EBUS)-guided transbronchial needle aspiration. However, there are no studies documenting the safety of aspirin in patients undergoing therapeutic bronchoscopy. The aim of this study is to evaluate whether aspirin increases the risk of bleeding following therapeutic bronchoscopy. Methods: This was a retrospective study to determine if there was a higher risk of bleeding in patients on aspirin undergoing therapeutic bronchoscopy compared with those not on aspirin. Patient characteristics were reported by cohort using the mean, median, and standard deviation for continuous variables, and using frequencies and relative frequencies for categorical variables. Results: Of the 108 patients who had multimodality therapeutic bronchoscopy, 17 (15.7%) were taking aspirin and 91 (84.3%) were not on aspirin. Patients in the aspirin group were older than those in the no aspirin group (median age: 66 versus 60 years, p = 0.007). The treatment modalities were similar in both groups except that more patients in the no aspirin group were treated with argon plasma coagulation (APC) compared to the aspirin group (60.4% versus 29.4%, p = 0.031). The estimated blood loss (EBL) between the aspirin and no aspirin groups was not significantly different (mean: 6.0 versus 6.7 ml; median: 5.0 versus 5.0, p = 0.36). Overall, there was no difference in complications between both groups. Conclusion: Aspirin use was not associated with increased risk of bleeding or procedurerelated complications after therapeutic bronchoscopy.

show abstract

Section: Discussionmentioning

confidence: 99%

Aspirin use and the risk of bleeding complications after therapeutic bronchoscopy

Harris

Kebbe

Modi

et al. 2016

Ther Adv Respir Dis

View full text Add to dashboard Cite

show abstract

“…Внедрённая в клиническую практику методика кла-панной бронхоблокации, которая активно исполь-зуется во фтизиохирургии для лечения пациентов с хронической обструктивной болезнью лёгких, при-меняется и в практике торакальных отделений [2,3,5,6,11,13,14,15,16,17].…”

Section: Introductionunclassified

“…Увеличившееся число паци-ентов с буллезной эмфиземой лёгких, осложнённой пневмотораксом, послеоперационная утечка воз-духа по плевральным дренажам (несостоятельность культи бронха, швов лёгкого), бронхоплевральные свищи при деструкции лёгочной ткани ухудшают результаты лечения, прогноз и течение заболевания [1,2,4,10,12,16].Для устранения бронхоплеврального свища предложены различные варианты окклюзии брон-ха, однако они не всегда гарантируют прекращение …”

unclassified

Valvular Bronchial Closure in the Treatment of Bronchopleural Fistulas

Дробязгин¹,

Drobyazgin²,

Чикинев³

et al. 2017

Acta Biomedica Scientifica

View full text Add to dashboard Cite

КЛАПАННАЯ БРОНХОБЛОКАЦИЯ ПРИ ЛЕЧЕНИИ БРОНХОПЛЕВРАЛЬНЫХ СВИЩЕЙ ВВЕДЕНИЕПроблема лечения пациентов с бронхоплевраль-ными свищами остаётся актуальной в современной торакальной хирургии. Увеличившееся число паци-ентов с буллезной эмфиземой лёгких, осложнённой пневмотораксом, послеоперационная утечка воз-духа по плевральным дренажам (несостоятельность культи бронха, швов лёгкого), бронхоплевральные свищи при деструкции лёгочной ткани ухудшают результаты лечения, прогноз и течение заболевания [1,2,4,10,12,16].Для устранения бронхоплеврального свища предложены различные варианты окклюзии брон-ха, однако они не всегда гарантируют прекращение

show abstract

“…15 of 19 had prolonged air leak one week after treatment and 11 had it longer than two or more weeks. Two patients with central BPF had postpneumonectomy fistula and were treated with the combination of a stent and a valve, one of them successfully, and the other unsuccessfully, followed by surgery [28]. The second study retrospectively enrolled 14 patients treated for peripheral BPF with overall success in six patients in the "medical group" (50%) and for eight in the "surgical group" (62.5%).…”

Section: Bronchoscopic Treatment Of Bronchopleural Fistulamentioning

confidence: 99%

Bronchoscopic management of bronchopleural fistula

Stamenovic¹

2016

Curr Thorac Surg

View full text Add to dashboard Cite

Bronchopleural fistula (BPF) represents a pathological communication between any part of bronchial tree and the pleural space. Mostly it is a rare yet serious complication of different pulmonary conditions like certain infections, trauma, malignancy and/or surgery, going along with significant mortality reported to be as high as 58%. Diagnosis of BPF is mostly done by evaluating these three data: clinical appearance, bronchoscopy and CT scan. The treatment of BPF may initially differ according to the time of appearance as well as clinical presentation. As most BPF goes along with empyema, it is, obviously, necessary to deal with it. This is most commonly achieved with a chest tube. Conservative management of BPF can be achieved using a significant variety of materials and methods with reportedly moderate to excellent results in the treatment of etiologically and sizably different BPF. Methyl-2-cyanoacrylate, fibrin sealant together with spongy calf bone, polidocanol -hydroxypolyethoxidodecane, amplatzer device, silver nitrate, stenting and endobronchial valves have all been employed in bronchoscopic treatment of a BPF. There is no evidence based guideline for its management, either surgically or endoscopically. The treatment of choice is always in the hands of the physician, preferably armed with the current knowledge and capacity of utilizing it.

show abstract

Endobronchial Valves for Challenging Air Leaks

Cited by 62 publications

References 26 publications

Aspirin use and the risk of bleeding complications after therapeutic bronchoscopy

Aspirin use and the risk of bleeding complications after therapeutic bronchoscopy

Valvular Bronchial Closure in the Treatment of Bronchopleural Fistulas

Bronchoscopic management of bronchopleural fistula

Contact Info

Product

Resources

About